SRC and neoplasm: Yi ZF et al [25] found that a short 11-amino acid peptide (KV11) derived from apoA1 inhibits tumor growth by regulating cell migration and tumor angiogenesis by selectively blocking the VEGF-induced c-Src signaling pathway.